Phillips Elyse, Wang Teresa W, Husten Corinne G, Corey Catherine G, Apelberg Benjamin J, Jamal Ahmed, Homa David M, King Brian A
MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1209-1215. doi: 10.15585/mmwr.mm6644a2.
Tobacco use remains the leading cause of preventable disease and death in the United States (1). Despite declining cigarette smoking prevalence among U.S. adults, shifts in the tobacco product landscape have occurred in recent years (2,3). Previous estimates of tobacco product use among U.S. adults were obtained from the National Adult Tobacco Survey, which ended after the 2013-2014 cycle. This year, CDC and the Food and Drug Administration (FDA) assessed the most recent national estimates of tobacco product use among adults aged ≥18 years using, for the first time, data from the 2015 National Health Interview Survey (NHIS), an annual, nationally representative, in-person survey of the noninstitutionalized U.S. civilian population. The 2015 NHIS adult core questionnaire included 33,672 adults aged ≥18 years, reflecting a 55.2% response rate. Data were weighted to adjust for differences in selection probability and nonresponse, and to provide nationally representative estimates. In 2015, 20.1 % of U.S. adults currently (every day or some days) used any tobacco product, 17.6% used any combustible tobacco product, and 3.9% used ≥2 tobacco products. By product, 15.1% of adults used cigarettes; 3.5% used electronic cigarettes (e-cigarettes); 3.4% used cigars, cigarillos, or filtered little cigars; 2.3% used smokeless tobacco; and 1.2% used regular pipes, water pipes, or hookahs.* Current use of any tobacco product was higher among males; persons aged <65 years; non-Hispanic American Indian/Alaska natives (AI/AN), whites, blacks, and persons of multiple races; persons living in the Midwest; persons with a General Educational Development (GED) certificate; persons with annual household income of <$35,000; persons who were single, never married, or not living with a partner or divorced, separated, or widowed; persons who were insured through Medicaid or uninsured; persons with a disability; and persons who identified as lesbian, gay, or bisexual (LGB). Current use of any tobacco product was 47.2% among adults with serious psychological distress compared with 19.2% among those without serious psychological distress. Proven population-level interventions that focus on the diversity of tobacco product use are important to reducing tobacco-related disease and death in the United States (1).
在美国,烟草使用仍然是可预防疾病和死亡的首要原因(1)。尽管美国成年人吸烟率呈下降趋势,但近年来烟草产品格局已发生变化(2,3)。此前对美国成年人烟草产品使用情况的估计来自全国成人烟草调查,该调查在2013 - 2014周期后结束。今年,美国疾病控制与预防中心(CDC)和食品药品监督管理局(FDA)首次使用2015年全国健康访谈调查(NHIS)的数据,评估了18岁及以上成年人烟草产品使用情况的最新全国估计值。NHIS是一项针对美国非机构化平民人口的年度、具有全国代表性的面对面调查。2015年NHIS成人核心问卷涵盖了33672名18岁及以上成年人,回复率为55.2%。数据经过加权处理,以调整选择概率和无回复情况的差异,并提供具有全国代表性的估计值。2015年,20.1%的美国成年人目前(每天或有时)使用任何烟草产品,17.6%使用任何可燃烟草产品,3.9%使用两种及以上烟草产品。按产品类型来看,15.1%的成年人使用香烟;3.5%使用电子烟;3.4%使用雪茄、小雪茄或过滤小雪茄;2.3%使用无烟烟草;1.2%使用普通烟斗、水烟袋或水烟筒*。男性、年龄小于65岁者、非西班牙裔美国印第安人/阿拉斯加原住民(AI/AN)、白人、黑人以及多种族人群、居住在中西部地区的人、拥有普通教育发展证书(GED)的人、家庭年收入低于35000美元的人、单身、从未结婚、未与伴侣同住或离婚、分居或丧偶的人、通过医疗补助计划参保或未参保的人、残疾人士以及自我认同为女同性恋、男同性恋或双性恋(LGB)的人,当前使用任何烟草产品的比例更高。有严重心理困扰的成年人中,当前使用任何烟草产品的比例为47.2%,而无严重心理困扰的成年人中这一比例为19.2%。事实证明,针对烟草产品使用多样性的人群层面干预措施对于减少美国与烟草相关的疾病和死亡至关重要(1)。